HCC Cholate- Hepatic functional deterioration after radiation therapy for hepatocellular carcinoma measured by hepatic cholate clearance
Brief description of study
In this study, subjects diagnosed with liver cancer undergo the HepQuant SHUNT diagnostic assay as a means to determine liver function. The results of this assay will potentially inform radiation treatment.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Hepatocellular carcinoma,Liver cancer,Childs-Pugh B
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
16 Oct 2020.
Study ID: 843529